The Impact of The Supply Chain on Residential Home Prices

In this episode of Location Cubed, host Rob Nowak, a Tax Partner with Weaver, sat down with Howard Altshuler, Weaver’s Partner-in-Charge of Real Estate Services. The two discussed the impact of the supply chain on the recent spike in residential home prices.

Pre-covid, everything was moving along fairly smoothly for the supply chain; however, COVID-19 brought restrictions, lockdowns, and people hoarding things. “It kind of started to gum up the supply chain,” Altshuler said. “Traffic internationally started slowing down, and it’s almost like it comes to a stop, and then it takes a while to start up.”

According to statistics, if you were to shut down the supply chain for a year, it takes about three to five years to set it back up to full capacity from both a production and logistics standpoint. “That’s a lot of what we are dealing with from a standpoint of materials in any type of stuff,” Altshuler said.

Not surprisingly, this relates to the recent spike in residential home prices. “Building material prices are way higher if you can get them. That’s obviously turning into higher home prices,” Altshuler said. Demand is the second component of this. Months of inventory fell to 1.4 months as active listings remained retracted while demands skyrocket, according to data from the Texas A&M’s Texas Real Estate Research Center.

The two discussed alternatives to homeownership, including the build-to-rent model being a remedy for the home supply shortages and the sustainability of positive growth rates in non-metro areas compared to negative rates for metro areas as remote work persists.

Follow us on social media for the latest updates in B2B!

Image

Latest

physician advisor
Navigating Payer Denials: A Physician Advisor’s Perspective #2
December 2, 2025

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Read More
Inside ERISA Denials: Why Employers May Be the Real Decision-Makers Behind Your Insurance Card
December 2, 2025

Insurance denials aren’t new, but they’re hitting a breaking point right now. As prior authorizations surge and patients face longer delays for everything from imaging to specialty drugs, more providers are realizing that the “payer” on the card often isn’t the one truly holding the reins. A growing share of Americans are covered…

Read More
Laying Out the Landscape in Today’s Patient Monitoring
Laying Out the Landscape in Today’s Patient Monitoring
December 2, 2025

More and more hospital environments rely on continuous, high-quality data to support faster clinical decisions, but much of today’s patient monitoring still varies widely by unit, device, and workflow. This episode kicks off a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring. Intel’s Kaeli Tully, Solutions Engineer…

Read More
Culture
People-Centric HR in Practice: How Jen Schomer Turns Organizational Chaos into a Culture of Trust and Performance
December 2, 2025

In today’s whiplash workplace—where startups scale fast, funding dries up faster, and employee expectations keep evolving—HR isn’t a back-office function anymore. The rise of fractional leadership, remote teams, and constant regulatory change has forced companies to rethink how they support people while still hitting business goals. Leaders are realizing that “culture issues” often trace…

Read More